Yunkang Group Ltd. logo

Yunkang Group Ltd. (2325)

Market Open
7 Aug, 08:00
HKEX HKEX
0. 64
HKD
+0.01
+1.5873%
HKD
3.95B Market Cap
- P/E Ratio
- Div Yield
27,000 Volume
- Eps
0.63 HKD
Previous Close
Add Transaction
Day Range
0.58 0.64
Year Range
0.55 3.32
Want to track 2325 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

2325 trading today higher at 0.64 HKD, an increase of 1.5873% from yesterday's close, completing a monthly decrease of -5.8824% or -0.04 HKD. Over the past 12 months, 2325 stock lost -36%.
2325 is not paying dividends to its shareholders.
The last earnings report, released on Feb 25, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

2325 Chart

People also search for

CSSC Hong Kong Shipping Co., Ltd.
2.15 HKD
-0.9217%
Envision Greenwise Holdings Inc.
4.84 HKD
+0.6231%
Hangzhou SF Intra-city Industrial Co., Ltd.
8.03 HKD
-2.3708%
COSCO SHIPPING International
5.75 HKD
-1.7094%
Autostreets Development Ltd.
1.52 HKD
+2.6936%

Yunkang Group Ltd. (2325) FAQ

What is the stock price today?

The current price is 0.64 HKD.

On which exchange is it traded?

Yunkang Group Ltd. is listed on HKEX.

What is its stock symbol?

The ticker symbol is 2325.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 3.95B.

Has Yunkang Group Ltd. ever had a stock split?

No, there has never been a stock split.

Yunkang Group Ltd. Profile

Professional Services Industry
Industrials Sector
Mr. Yong Zhang CEO
HKEX Exchange
KYG9889T1067 ISIN
China Country
1,459 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Yunkang Group Limited is a distinguished medical operation service provider based in the People's Republic of China. Since its inception in 2008, with headquarters in Guangzhou, the company has been at the forefront of offering diagnostic testing services. Yunkang Group Limited caters to medical institution alliances, financial institutions, and insurance companies. It is renowned for its comprehensive support in establishing or enhancing diagnostic centers, implementing standard operating procedures, and providing state-of-the-art diagnostic consultation and staff training. Additionally, the company plays a crucial role in the procurement of medical equipment, leveraging smart internet technologies, and facilitating efficient logistics operations.

Products and Services

  • Diagnostic Testing Services for Medical Institution Alliances

    Yunkang Group provides an extensive array of diagnostic testing services tailored for medical institution alliances. This includes the development or improvement of diagnostic centers, formulation of standard operating procedures, and offering expert diagnostic consultation. The company also specializes in staff training programs, sourcing cutting-edge equipment, and integrating smart internet of things solutions to streamline diagnostic processes. Logistic assistance is another critical facet of their services, ensuring efficient operation of diagnostic centers.

  • Diagnostic Outsourcing Services

    The company offers diagnostic outsourcing services that cover a wide spectrum of tests. These include pathology tests, infectious disease diagnostic tests such as for hepatitis B virus, tuberculosis, human papilloma virus, EB virus, rabies virus, and comprehensive nucleic acid tests for various respiratory pathogens. Additionally, Yunkang Group provides genetic reproduction and screening tests alongside routine diagnostic examinations targeting chronic kidney disease, blood disorders, autoimmune diseases, and endocrine metabolism afflictions.

  • Diagnostic Testing Services for Financial Institutions and Insurance Companies

    Yunkang Group extends its diagnostic testing services to financial institutions and insurance companies, offering personalized diagnostic testing, medical report consultation, and hospital referral services. This suite of services is designed to cater to the specific needs of financial and insurance sectors, providing them with accurate medical assessments needed for their operations.

  • Healthcare Technology and Logistics

    Besides diagnostic services, the company is involved in healthcare technology development, encompassing information technology solutions, medical logistics, and procurement of medical equipment. These services are integral to enhancing the efficiency and effectiveness of healthcare delivery.

  • Project Investment

    Yunkang Group is not only a service provider but also engages in project investment. By investing in healthcare technology projects, the company aims to spearhead innovation in the medical sector, ensuring the delivery of state-of-the-art healthcare services.

Contact Information

Address: No. 9 Yayingshi Road
Phone: 86 20 3210 6666